NASDAQ:ALKS
Alkermes plc Stock News
$24.68
+0.240 (+0.98%)
At Close: Apr 26, 2024
Journal of Clinical Psychiatry Publishes Data from Alkermes' Phase 3 ENLIGHTEN-1 Efficacy Study of ALKS 3831 in Patients With Schizophrenia
12:00pm, Wednesday, 04'th Mar 2020
Alkermes plc (Nasdaq: ALKS) today announced the publication of results from the phase 3 ENLIGHTEN-1 clinical trial of ALKS 3831 (olanzapine/samidorphan) in the peer-reviewed publication, Journal of Cl
Alkermes (NASDAQ:ALKS) Upgraded to "Hold" by BidaskClub
08:28am, Wednesday, 04'th Mar 2020
Alkermes (NASDAQ:ALKS) was upgraded by research analysts at BidaskClub from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Wednesday, BidAskClub rep
The 5 Best Stocks (And 5 Worst) of the Coronavirus Correction
09:02pm, Monday, 02'nd Mar 2020
The rapid spread of the COVID-19 coronavirus is wreaking havoc across the equity market. The S&P; 500 lost nearly 13% from Feb. 19 to Feb. 28 - the fastest descent from all-time highs into correction
Alkermes Plc (NASDAQ:ALKS) Shares Bought by Charles Schwab Investment Management Inc.
12:06pm, Monday, 02'nd Mar 2020
Charles Schwab Investment Management Inc. boosted its stake in shares of Alkermes Plc (NASDAQ:ALKS) by 4.7% in the fourth quarter, HoldingsChannel.com reports. The fund owned 1,148,001 shares of the c
Short Interest in Alkermes Plc (NASDAQ:ALKS) Grows By 14.3%
06:34am, Sunday, 01'st Mar 2020
Alkermes Plc (NASDAQ:ALKS) was the recipient of a significant growth in short interest during the month of February. As of February 14th, there was short interest totalling 6,090,000 shares, a growth
Stocks To Watch: Time For Coronavirus Offense Or Defense?
01:26pm, Saturday, 29'th Feb 2020
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive th
The Independent Director of Alkermes plc (NASDAQ:ALKS), Nancy Wysenski, Just Bought 161% More Shares
10:32am, Friday, 28'th Feb 2020
Potential Alkermes plc (NASDAQ:ALKS) shareholders may wish to note that the Independent Director, Nancy Wysenski...
The Independent Director of Alkermes plc (NASDAQ:ALKS), Nancy Wysenski, Just Bought 161% More Shares
10:29am, Friday, 28'th Feb 2020
Potential Alkermes plc (NASDAQ:ALKS) shareholders may wish to note that the Independent Director, Nancy Wysenski...
